Micronanoparticled risedronate exhibits potent vaccine adjuvant effects [RNA-Seq]
RNA-seq (gene expression) · mouse · 12 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 12 samples: 6 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE239643_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1000477 and SRA study SRP452328. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 12 samples.
How we read this: 6 replicated groups read from 12 sample titles; they account for 12 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7669274 6 weeks female mouse muscle, treated with S/AlPi 6h, replication 1 6 weeks female mouse mu…
- GSM7669275 6 weeks female mouse muscle, treated with S/AlPi 6h, replication 2 6 weeks female mouse mu…
- GSM7669276 6 weeks female mouse muscle, treated with S/Zn-RS 6h, replication 1 6 weeks female mouse mu…
- GSM7669277 6 weeks female mouse muscle, treated with S/Zn-RS 6h, replication 2 6 weeks female mouse mu…
- GSM7669278 6 weeks female mouse muscle, treated with S/AlPi 24h, replication 1 6 weeks female mouse mu…
- GSM7669279 6 weeks female mouse muscle, treated with S/AlPi 24h, replication 2 6 weeks female mouse mu…
- GSM7669280 6 weeks female mouse muscle, treated with S/Zn-RS 24h, replication 1 6 weeks female mouse mu…
- GSM7669281 6 weeks female mouse muscle, treated with S/Zn-RS 24h, replication 2 6 weeks female mouse mu…
- GSM7669282 6 weeks female mouse muscle, treated with S/AlPi 72h, replication 1 6 weeks female mouse mu…
- GSM7669283 6 weeks female mouse muscle, treated with S/AlPi 72h, replication 2 6 weeks female mouse mu…
- GSM7669284 6 weeks female mouse muscle, treated with S/Zn-RS 72h, replication 1 6 weeks female mouse mu…
- GSM7669285 6 weeks female mouse muscle, treated with S/Zn-RS 72h, replication 2 6 weeks female mouse mu…
- GSE239646 Micronanoparticled risedronate exhibits potent vaccine adjuvant effects [scRNA-Seq] 9 samples shares micronanoparticled, risedronate, exhibits, adjuvant, vaccine, rna-seq, potent
- GSE239649 Micronanoparticled risedronate exhibits potent vaccine adjuvant effects 21 samples shares micronanoparticled, risedronate, exhibits, adjuvant, vaccine, potent
- GSE246438 Novel lipid nanoparticle adjuvants vaccine for porcine reproductive and respiratory syndrome (PRRS) using in-vitro macrophage assays 36 samples shares adjuvant, vaccine
- GSE255778 Glycan adjuvantation expands the breadth and duration of protection of a mRNA-based vaccine 30 samples shares adjuvant, vaccine
- GSE279372 Lipid nanoparticles as adjuvant of Norovirus VLP vaccine augment cellular and humoral immune responses in a TLR 9- and type I IFN-dependent pathway 28 samples shares adjuvant, vaccine
- GSE303696 Dynamic change of immune microenvironment in ovarian cancer following neoadjuvant chemotherapy [scRNA-seq] 12 samples shares adjuvant, rna-seq
- GSE290067 An enantiomer-dependent and modification-free DNA matrix as a novel adjuvant platform for subunit vaccines 9 samples shares adjuvant, vaccine
- GSE314070 Parenteral Vaccination with an Adjuvanted mRNA Vaccine Induces Protective Mucosal Immunity Against Rotavirus in neonatal mice 9 samples shares adjuvant, vaccine
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.